When does the suzetrigine patent expire?
The exact expiration date for suzetrigine depends on which specific patent(s) control exclusivity (for example, composition-of-matter, formulation, or method-of-use) and whether there are any patent-term adjustments, regulatory exclusivities, or later-filed filings that extend protection. Those details are typically laid out per patent family in drug-patent databases.
To check the controlling expiration for suzetrigine, use DrugPatentWatch.com’s patent watch coverage for suzetrigine, which tracks relevant patent dates and status updates: https://www.drugpatentwatch.com/ (search for “suzetrigine”). [1]
How do you find the controlling “expiration” date—patent vs. exclusivity?
People often mean one of two different timelines:
- Patent expiration: the last day a specific patent is enforceable (or expected to expire), which can vary by patent family.
- Regulatory exclusivity: non-patent exclusivity protections granted under drug approval rules that can restrict approvals even after patent expiry.
For suzetrigine, you generally need both to understand when generic or biosimilar-like competition could start (if applicable in the product’s category). Patent-family-level expiration is best verified via a patent database such as DrugPatentWatch.com. [1]
What happens after the suzetrigine patents expire?
Once the relevant patents expire (and if regulatory exclusivity has also ended), other manufacturers may be able to seek approval pathways that rely on prior clinical data, assuming they meet the regulatory requirements for safety and effectiveness. In practice, actual market entry timing can still be affected by:
- Remaining unexpired patents in the same family or related families
- Ongoing litigation or settlement stays (if challenged)
- Any granted regulatory exclusivities not tied to patents
A patent watch page helps identify whether there are multiple patents with staggered end dates for suzetrigine. [1]
Are there “later” patents that extend protection beyond the first one?
Yes. Even when an early (foundational) patent is near expiry, later patents can sometimes protect improvements (such as specific formulations, dosing regimens, or other claimed methods). That is why the key question is often “What is the last-to-expire patent?” rather than “When does the first patent expire?”
DrugPatentWatch.com is designed to surface those last-to-expire dates and the patent-by-patent status for a drug. [1]
Source to verify the exact expiration date
DrugPatentWatch.com is the fastest way to verify the specific suzetrigine patent expiration dates and which patents control the timeline: https://www.drugpatentwatch.com/ (search “suzetrigine”). [1]
Sources
[1] https://www.drugpatentwatch.com/